Latest Breaking News On - Takeaim leukemia - Page 1 : vimarsana.com

Emavusertib Represents Safe, Manageable IRAK4 Inhibitor in FLT3- and Splicing Factor–Mutated AML

Eric Winer, MD, discusses the safety and efficacy outcomes of the TakeAim Leukemia trial and future research with emavusertib in combination therapies.

Dana farber cancer instituteUnited statesEric winerHarvard medical schoolTakeaim leukemiaAdult leukemia

StreetInsider com - Corporate News

StreetInsider com - Corporate News
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pmluokung technologyTakes further stepsAdvance returnGrowth strategyAnnounces dividendOfficial electric vehicle chargerNetwork services providerSigns supply agreementNovel endocrinologicalAnnounces additional dataTakeaim leukemiaRolls out spacexStarlink across entire global

Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study

Curis (CRIS) Announces Additional Data from TakeAim Leukemia Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Robert martellJames dentzerCuris incTakeaim leukemiaRecommended phaseChief scientific officer

Curis to Present Updated Data from the TakeAim Leukemia Study

Curis to Present Updated Data from the TakeAim Leukemia Study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesPrnewswire curis incTakeaim leukemia

Emavusertib Progresses to Phase 2 Study in AML and MDS

The TakeAim Leukemia trial aims to add emavusertib to the treatment paradigm of acute myeloid leukemia and high-risk myelodysplastic syndrome.

United statesDana farber cancer instituteSan diegoErics winerAlices mimsCuris incDivision of hematologyHarvard medical schoolAmerican society of hematology annual meeting expositionLeukemia clinical researchOhio state university comprehensive cancer centerAim leukemiaTakeaim leukemiaAdult leukemiaAcute leukemia clinical researchFindings demonstrate efficacy